Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.
Korean J Physiol Pharmacol. 2008 Dec;12(6):293-7. doi: 10.4196/kjpp.2008.12.6.293. Epub 2008 Dec 31.
The effect of forskolin on corticostriatal synaptic transmission was examined by recording excitatory postsynaptic currents (EPSCs) in rat brain slices using the whole-cell voltage-clamp technique. Forskolin produced a dose-dependent increase of corticostriatal EPSCs (1, 3, 10, and 30 microM) immediately after its treatment, and the increase at 10 and 30 microM was maintained even after its washout. When the brain slices were pre-treated with (DL)-2-amino-5-phosphonovaleric acid (AP-V, 100 microM), an NMDA receptor antagonist, the acute effect of forskolin (10 microM) was blocked. However, after washout of forskolin, an increase of corticostriatal EPSCs was still observed even in the presence of AP-V. When KT 5720 (5 microM), a protein kinase A (PKA) inhibitor, was applied through the patch pipette, forskolin (10 microM) increased corticostriatal EPSCs, but this increase was not maintained. When forskolin was applied together with AP-V and KT 5720, both the increase and maintenance of the corticostriatal EPSCs were blocked. These results suggest that forskolin activates both NMDA receptors and PKA, however, in a different manner.
采用全细胞膜片钳技术记录大鼠脑片的兴奋性突触后电流(EPSC),观察到福司可林对皮质纹状体突触传递的影响。福司可林处理后立即产生剂量依赖性的皮质纹状体 EPSC 增加(1、3、10 和 30 μM),并且在 10 和 30 μM 时即使在冲洗后仍保持增加。当脑片用 NMDA 受体拮抗剂(DL)-2-氨基-5-磷戊酸(AP-V,100 μM)预处理时,福司可林(10 μM)的急性作用被阻断。然而,在福司可林冲洗后,即使在存在 AP-V 的情况下,仍观察到皮质纹状体 EPSC 的增加。当通过膜片钳内液施加蛋白激酶 A(PKA)抑制剂 KT 5720(5 μM)时,福司可林(10 μM)增加皮质纹状体 EPSC,但这种增加不能维持。当福司可林与 AP-V 和 KT 5720 一起应用时,皮质纹状体 EPSC 的增加和维持均被阻断。这些结果表明,福司可林以不同的方式激活 NMDA 受体和 PKA,但方式不同。